Evidence that the Human Innate Immune Peptide LL-37 may be a Binding Partner of Amyloid-β and Inhibitor of Fibril Assembly
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Alzheimer's Disease"
DOI: 10.3233/jad-170223
Abstract: Background: Identifying physiologically relevant binding partners of amyloid-β (Aβ) that modulate in vivo fibril formation may yield new insights into Alzheimer’s disease (AD) etiology. Human cathelicidin peptide, LL-37, is an innate immune effector and modulator,… read more here.
Keywords: two peptides; evidence; evidence human; fibril formation ... See more keywords